Abstract
with type 2 diabetes (mean age±SD=61±10 years, female patient groups are summarized in Table 1 . The prevalto male ratio 658) and 16 without diabetes (age=60±10 ence of pathological nutritional parameters are shown years, female to male ratio 759). The mean duration of in Table 2 . The prevalence of pathological nutritional haemodialysis was 29±15 months among diabetic patients parameters tended to be higher in diabetic patients, and 31±13 months among non-diabetic individuals. All however, the differences were not statistically significpatients were dialysed three times a week for 4-5 h. This ant. There was no significant correlation (r=0.381) schedule was maintained during the entire period of observa-between BMI and the serum albumin concentration tion (diabetic patients 13.5±1.3 vs 12.5±1.1 h/week for the ( Figure 1) for the diabetic patients. The residual diurnon-diabetic patients). Cuprophan dialysers with a memesis was similar in both groups, only three (21%) brane surface of 1.2-1.5 m2 were used for the majority of patients, two diabetic and three non-diabetic subjects were diabetic patients and five (31%) non-diabetic indihaemodialysed with polysulfone filters. Metabolic control of viduals had urine excretion Á100 ml/day; the mean the diabetic patients was achieved by insulin substitution in urinary loss of protein in all diabetic and non-diabetic eight cases, by sulfonyl urea therapy in two cases and by patients was not significantly different (126±32 diet in four individuals. The primary renal diseases of the mg/day vs 102±88 mg/day).
non-diabetic patients were chronic glomerulonephritis (n= 10), chronic interstitial nephritis (n=4) and arterionephrosclerosis (n=2). The diagnosis of glomerulonephritis was Discussion confirmed by renal biopsy in eight cases; in all other patients renal disease was clinically diagnosed. Diagnosis of diabetic nephropathy was based on the demonstration of persistent Protein-calorie malnutrition in dialysis patients is assoproteinuria (>0.5 g protein/24 h-urine) and normal urine ciated with higher mortality and morbidity [11, 12] . sediment in the presence of chronic diabetes.
Malnutrition is common (30-40%) in patients on mainWe measured body weight (dry weight and weight at the tenance haemodialysis [2] and can be caused by low end of haemodialysis), serum cholesterol, pre-dialysis creatin-nutrient intake, concomitant illnesses and inadequacy ine and blood urea nitrogen (BUN ), total protein, serum of dialysis treatment [1] . Serum albumin level was the albumin (Hitachi 750 autoanalyser) and inter-dialytic weight strongest predictor of mortality in all studies [2, 4] , and gain [5] . In patients with significant residual diuresis correlated best with clinical nutritional assessment [6 ] .
(Á100 ml urine/day) we also measured urinary protein excretion (by the Biuret method ). No patient had oedema at the time of investigation. Additionally, a single investigator Table 1 . Body mass index (BMI ), nutritional parameters, protein performed a subjective global assessment (SGA) of the catabolic rate (PCR) and Kt/V (mean±SD) of the patients with and without type 2 diabetes after ∏18 months haemodialysis therapy nutritional status of all patients [6 ] . The protein intake was estimated by nPCR at the end of the study according to the formula of Gotch and Sargent [8] , and the adequacy of other measurements were approximately the same; only weight gain was significantly higher among diabetic subjects. All parameters (mean±SE ) of the two *n.s.
Fig. 1.
Correlation between BMI and serum albumin concentration in the type 2 diabetic patients after ∏18 months on haemodialysis therapy; r-value=0.381 (n.s.).
However, this correlation was not confirmed by other Many of the diabetic patients (n=9/14, 64%) were still overweight after Á18 months of haemodialysis authors [13] . Malnourished patients have a serum albumin level <3.5 g/dl, while patients with an albu-therapy. The prevalence of overweight patients was greater in the group of surviving diabetic patients on min concentration <3.0 g/dl show a higher incidence of death [3] . Other nutritional parameters such as haemodialysis than in those who died. At the start of dialysis therapy the mean BMI of the non-survivors serum total protein, pre-albumin, transferrin and cholesterol did not have the same specificity. Interdialysis was 22±3 in contrast to 29±8 of the survivors (P>0.01). weight gain has also been described as a nutritional marker, a weight gain <2 kg/day is associated with a
In our surviving patients, we found no correlation between total body weight, BMI and serum albumin, lower nPCR [5] .
In our study, only the mean serum albumin levels the latter being the strongest predictor for mortality in haemodialysis patients. For diabetic subjects, this phewere significantly lower among type 2 diabetics compared with non-diabetic individuals ( Table 1 ). The nomenon is illustrated in Figure 1 (r-value=0.381, n.s.). The mean serum albumin concentration among majority of diabetic patients were still overweight with haemodialysis therapy (64% vs 44% of the non-diabetic diabetic patients who were severely overweight (BMIÁ30, n=7) was approximately the same as that subjects). The lower albumin levels could not be explained by malnutrition in these patients; the preval-in diabetic individuals with a lower body weight (3184±151 mg/dl vs 3240±320 mg/dl ) (n=7). The ence of all other pathological markers for malnutrition showed a tendency to be higher in the diabetic patient protein intake estimated by nPCR was similar among patients with and without diabetes. In addition, Kt/V group, but the differences were not statistically significant with the exception of interdialysis weight as a parameter for the quality of haemodialysis [15] did not differ among the two patients groups. gain which was higher among diabetics ( Table 2) . Moreover, a significant loss of albumin in urine could In summary, the prevalence of malnutrition was not significantly higher in type 2-diabetic patients than in be excluded as a reason for lower albumin levels in our diabetic subjects. Total protein concentrations were age-matched non-diabetic patients after Á18 months of haemodialysis therapy. The lower serum albumin approximately the same in both patient groups.
It has been reported in the literature that a higher levels of patients with type 2 diabetes may be partly explained by more frequent intercurrent illnesses. The dose of dialysis can improve serum albumin levels [14] . However, there was no significant difference in Kt/V influence of residual urinary loss of protein on serum albumin concentrations was negligible in our patients. between both groups in our study. The lower serum albumin levels in our haemodialysis diabetic patients can be partially explained by a higher incidence of
